-
Something wrong with this record ?
Myocardial revascularisation in patients with severe left ventricular dysfunction. Early and midterm results
J. Skorpil, R. Brát, B. Docekal, O. Motyka
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
15523547
DOI
10.5507/bp.2004.009
Knihovny.cz E-resources
- MeSH
- Ventricular Dysfunction, Left complications physiopathology MeSH
- Coronary Artery Bypass MeSH
- Coronary Disease complications mortality surgery MeSH
- Middle Aged MeSH
- Humans MeSH
- Survival Rate MeSH
- Postoperative Complications MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
AIMS: This retrospective study evaluates early and midterm results in patients with severe left ventricular dysfunction. TECHNIQUE: Ninety-seven consecutive patients with coronary artery disease and ejection fraction of left ventricle (LVEF) less or equal to 25 % underwent elective coronary artery bypass graft procedure between September 1998 and December 2001. Mean age at operation was 66 (47-86) years. The main symptoms were angina class III-IV Canadian Cardiovascular Society (CCS) in 78 patients (80 %) and dyspnoea class III-IV New York Heart Association (NYHA) in 43 patients (44 %). The major indications for surgery were severe angina, dyspnoea in 90 patients (93 %). Cardiac index (CI), echocardiography (ECHO), planimetry, end-diastolic pressure of left ventricle (LVEDP), end-diastolic diameter of left ventricle (LVEDd) were used to access left ventricular function preoperatively. ECHO was also used to access left ventricular function postoperatively. RESULTS: Early postoperative (30 days) mortality was 4.1 %. Complications had 25 patients (26 %) postoperatively. Two years survival was 95.7 %. Class III-IV CCS and/or NYHA had 17 patients (17.5 %) two years after surgery. LVEF (assessed by ECHO) improved from 23.1 % preoperatively to 36.0 % postoperatively (p < 0.05). CONCLUSION: The study showed that elective myocardial revascularisation in patients with severe left ventricular dysfunction and signs of myocardial viability is not necessarily associated with high operative mortality. It can be performed safely with respectable midterm survival in concordance with left ventricular function improvement, symptom relief and quality of life improvement.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003843
- 003
- CZ-PrNML
- 005
- 20200715123530.0
- 007
- ta
- 008
- 130128s2004 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2004.009 $2 doi
- 035 __
- $a (PubMed)15523547
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Škorpil, Jiří. $7 mzk2014848780 $u Department of Cardiac Surgery, University Hospital Ostrava, Czech Republic. jiri.skorpil@seznam.cz
- 245 10
- $a Myocardial revascularisation in patients with severe left ventricular dysfunction. Early and midterm results / $c J. Skorpil, R. Brát, B. Docekal, O. Motyka
- 520 9_
- $a AIMS: This retrospective study evaluates early and midterm results in patients with severe left ventricular dysfunction. TECHNIQUE: Ninety-seven consecutive patients with coronary artery disease and ejection fraction of left ventricle (LVEF) less or equal to 25 % underwent elective coronary artery bypass graft procedure between September 1998 and December 2001. Mean age at operation was 66 (47-86) years. The main symptoms were angina class III-IV Canadian Cardiovascular Society (CCS) in 78 patients (80 %) and dyspnoea class III-IV New York Heart Association (NYHA) in 43 patients (44 %). The major indications for surgery were severe angina, dyspnoea in 90 patients (93 %). Cardiac index (CI), echocardiography (ECHO), planimetry, end-diastolic pressure of left ventricle (LVEDP), end-diastolic diameter of left ventricle (LVEDd) were used to access left ventricular function preoperatively. ECHO was also used to access left ventricular function postoperatively. RESULTS: Early postoperative (30 days) mortality was 4.1 %. Complications had 25 patients (26 %) postoperatively. Two years survival was 95.7 %. Class III-IV CCS and/or NYHA had 17 patients (17.5 %) two years after surgery. LVEF (assessed by ECHO) improved from 23.1 % preoperatively to 36.0 % postoperatively (p < 0.05). CONCLUSION: The study showed that elective myocardial revascularisation in patients with severe left ventricular dysfunction and signs of myocardial viability is not necessarily associated with high operative mortality. It can be performed safely with respectable midterm survival in concordance with left ventricular function improvement, symptom relief and quality of life improvement.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a koronární bypass $7 D001026
- 650 _2
- $a koronární nemoc $x komplikace $x mortalita $x chirurgie $7 D003327
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pooperační komplikace $7 D011183
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a dysfunkce levé srdeční komory $x komplikace $x patofyziologie $7 D018487
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Brát, Radim, $d 1962- $7 xx0080425 $u Department of Cardiac Surgery, University Hospital Ostrava, Czech Republic
- 700 1_
- $a Dočekal, Bohumil $7 xx0070697 $u Department of Cardiac Surgery, University Hospital Ostrava, Czech Republic
- 700 1_
- $a Motyka, Oldřich $7 xx0228211 $u Department of Cardiac Surgery, University Hospital Ostrava, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 148, č. 1 (2004), s. 55-58
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20200715123527 $b ABA008
- 999 __
- $a ok $b bmc $g 966496 $s 802038
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2004 $b 148 $c 1 $d 55-58 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK138 $a Pubmed-20130128